Aptamer-Based Proteomics

Aptamer-based proteomics refers to the use of nucleic acid aptamers to specifically recognize and bind to target proteins, thereby enabling qualitative and quantitative analysis of proteins. These nucleic acid aptamers are composed of nucleic acid sequences (such as DNA or RNA) and are selected from a large sequence library through in vitro selection technology (SELEX) for molecules with high affinity and specificity for specific proteins. Compared to traditional antibody detection technologies, aptamer-based proteomics shows significant advantages in specificity, stability, cost, and scalability. This technology is widely used in early disease diagnosis, biomarker discovery, drug target identification, and personalized medicine. In fields such as oncology, immune diseases, and neurodegenerative diseases, aptamer-based proteomics provides strong support for the analysis of disease molecular mechanisms and the optimization of treatment plans. With the development of technology and the expansion of application scenarios, aptamer-based proteomics is gradually becoming an integral part of proteomics research.

 

1. Common Methods of Aptamer-based Proteomics

1. SELEX Technology

SELEX (Systematic Evolution of Ligands by EXponential enrichment) is the core technology of aptamer-based proteomics. It involves multiple rounds of selection to pick nucleic acid aptamers with high affinity and specificity for the target protein from a random nucleic acid library.

 

2. High-throughput Detection Platforms

Using high-throughput nucleic acid chips or liquid chromatography-mass spectrometry (LC-MS) technology, interactions between nucleic acid aptamers and target proteins are detected on a large scale to achieve qualitative and quantitative analysis of proteins.

 

3. Fluorescent Labeling Method

By introducing fluorescent labels onto nucleic acid aptamers, real-time monitoring and quantification of proteins are achieved, particularly suitable for rapid screening of complex samples.

 

2. Technical Process

1. Target Protein Selection

Select target proteins based on research objectives, usually biomarkers, drug targets, or disease-related proteins.

 

2. Aptamer Selection

Conduct in vitro screening of nucleic acid aptamers using SELEX technology to ensure high affinity and specificity for target proteins.

 

3. Aptamer Modification and Optimization

Chemically modify the selected aptamers to enhance their stability and binding efficiency, adapting them to different experimental environments.

 

4. Proteomics Detection

Utilize aptamers to bind with target proteins in samples for high-throughput screening and data collection.

 

5. Data Analysis

Analyze proteomics data using bioinformatics tools to identify key proteins and their functional networks.

 

3. Advantages of Aptamer-based Proteomics Technology

1. High Specificity and Affinity

Aptamers can specifically bind to target proteins, reducing non-specific background noise.

 

2. Strong Stability

Aptamers exhibit good stability under varying environmental conditions such as temperature and pH, suitable for different sample conditions.

 

3. Cost-effectiveness

Compared to antibody preparation, the synthesis and selection of aptamers are less costly and have shorter production cycles.

 

4. Reproducibility

Nucleic acid aptamers have high consistency during synthesis, ensuring reproducibility of experimental results.

 

5. High Scalability

The sequence design and modification of aptamers are flexible, allowing specific recognition of different proteins.

 

With profound technical expertise and an experienced research team, Beritac Biotech provides professional aptamer-based proteomics services. Our services cover the entire process of aptamer selection, sample processing, protein identification, and data analysis, ensuring high-quality and accurate proteomics data. Whether in disease biomarker research, drug target discovery, or personalized medicine, Beritac is committed to providing efficient and precise solutions for clients. We look forward to closely collaborating with research partners to promote continuous innovation and development in the life sciences field.

 

Beritac Biotech - A Leading Provider of Biopharmaceutical Characterization and Multi-omics Mass Spectrometry Analysis Services

 

Related Services: